Area of research
Dermatology · Physiology
Research interest
Research interests include Dermatology and Skin Diseases, Asthma and respiratory diseases, Psoriasis: Treatment and Pathogenesis, and Allergic Rhinitis and Sensitization.
Evolution of pathologic B‐cell subsets and serum environment‐specific <scp>sIgEs</scp> in patients with atopic dermatitis and controls, from infancy to adulthood
COVID-19 symptoms are attenuated in atopic dermatitis patients treated with dupilumab Short running title: Reduced COVID-19 symptoms in dupilumab-treated AD
Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata.
Age of onset defines two distinct profiles of atopic dermatitis in adults.
Delayed type hypersensitivity reactions to various allergens may differently model inflammatory skin diseases.
Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients.
Tape strips capture atopic dermatitis-related changes in nonlesional skin throughout maturation.
Analysis of alopecia areata surveys suggests a threshold for improved patient-reported outcomes.
Th1, Th2 and Th17 inflammatory pathways synergistically predict cardiometabolic protein expression in serum of COVID-19 patients.
Tape strips from early-onset pediatric atopic dermatitis highlight disease abnormalities in nonlesional skin.
Vascular inflammation in moderate-to-severe atopic dermatitis is associated with enhanced Th2 response.
A Phase 1b, Randomized, Single-Center Trial of Topical Cerdulatinib (DMVT-502) in Patients with Mild-to-Moderate Atopic Dermatitis
SARS-CoV-2 receptor ACE2 protein expression in serum is significantly associated with age.
The role of circulating eosinophils on COVID-19 mortality varies by race/ethnicity.
A Nitric Oxide-Releasing Topical Medication as a Potential Treatment Option for Atopic Dermatitis through Antimicrobial and Anti-Inflammatory Activity.
A pan-cancer analysis of progression mechanisms and drug sensitivity in cancer cell lines.
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial
Alterations in Bronchial Airway miRNA Expression for Lung Cancer Detection
Integrating mutation and gene expression cross-sectional data to infer cancer progression
Integrative modeling of multi-omics data to identify cancer drivers and infer patient-specific gene activity